Other Information
−Removed: Commercial Lease Agreement, dated June 1, 2023, between Ozone Biotech, LLC and Co-Diagnostics, Inc.
−Removed: Co-Diagnostics, Inc.
−Removed: Change in Control Severance Plan, (Incorporated by reference herein from Form 8-K (Exhibit 10.1) filed May 16, 2023, SEC File No.
+Added: Exhibit Index
+Added: Number Description
+Added: Commercial Lease Agreement, dated September 18, 2023, between Ge Estate, LLC and Co-Diagnostics, Inc.
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
4 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: XBRL Instance Document
−Removed: XBRL Taxonomy Extension Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
−Removed: XBRL Taxonomy Extension Label Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Page Interactive Data File
+Added: Inline XBRL Instance Document
+Added: Inline XBRL Taxonomy Extension Schema Document
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document
+Added: Inline XBRL Taxonomy Extension Definition Linkbase Document
+Added: Inline XBRL Taxonomy Extension Label Linkbase Document
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Cover Page Interactive Data File
* Filed herewith.
−Removed: Management Contract or Compensatory Plan or Arrangement
−Removed: to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
−Removed: the undersigned thereunto duly authorized.
−Removed: CO-DIAGNOSTICS,
−Removed: August 10, 2023
−Removed: Executive Officer, President and Principal Executive Officer
−Removed: August 10, 2023
−Removed: Financial Officer and Principal Financial and Accounting Officer
+Added: # Management Contract or Compensatory Plan
+Added: or Arrangement
+Added: Pursuant to the requirements of the Securities Exchange
+Added: Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: CO-DIAGNOSTICS, INC.
+Added: November 9, 2023
+Added: /s/ Dwight H.
+Added: Chief Executive Officer, President and Principal Executive Officer
+Added: November 9, 2023
+Added: /s/ Brian Brown
+Added: Chief Financial Officer and Principal Financial and Accounting Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.